The synthesis of complex pharmaceuticals often relies on specialized organic intermediates that are meticulously produced to meet exacting standards. Ethyl (E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate, identified by its CAS number 148901-69-3, is one such critical compound. Its primary significance lies in its role as an advanced intermediate in the production of Pitavastatin, a potent statin drug used globally for managing high cholesterol levels.

This molecule is characterized by its intricate structure, which includes a quinoline heterocyclic core, a cyclopropyl substituent, and a 4-fluorophenyl group attached to the quinoline ring, along with a functionalized heptenoate side chain. The precise arrangement of these chemical moieties is essential for its function as a precursor in the synthesis of Pitavastatin. For pharmaceutical chemists and procurement managers seeking to buy this compound, understanding its chemical properties and purity specifications is paramount. Typically, it is supplied as a solid with a purity exceeding 99%, which is a non-negotiable requirement for pharmaceutical applications to prevent unwanted side reactions or impurities in the final drug product.

The demand for high-quality pharmaceutical intermediates like Ethyl (E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate is driven by the growing global market for cardiovascular drugs. Manufacturers of Pitavastatin rely on a stable and dependable supply chain to meet this demand. Identifying a reputable supplier or manufacturer that can consistently deliver this intermediate at a competitive price is a strategic imperative. When you choose to purchase from us, you are engaging with a leading supplier in China known for its commitment to quality, analytical rigor, and efficient logistics. We ensure that each batch meets the required CAS 148901-69-3 specifications, supporting your research and manufacturing endeavors.